International Agency for Research on Cancer, Lyon, France.
Hum Mutat. 2012 Jan;33(1):22-8. doi: 10.1002/humu.21629. Epub 2011 Nov 3.
Unclassified sequence variants (UVs) arising from clinical mutation screening of cancer susceptibility genes present a frustrating issue to clinical genetics services and the patients that they serve. We created an open-access database holding missense substitutions from the breast and ovarian cancer susceptibility genes BRCA1 and BRCA2. The main inclusion criterion is that each variant should have been assessed in a published work that used the Bayesian integrated evaluation of unclassified BRCA gene variants. Transfer of data on these substitutions from the original publications to our database afforded an opportunity to analyze the missense substitutions under a single model and to remove inconsistencies that arose during the evolution of the integrated evaluation over the last decade. This analysis also afforded the opportunity to reclassify these missense substitutions according to the recently published IARC 5-Class system. From an initial set of 248 missense substitutions, 31 were set aside due to nonnegligible probability to interfere with splicing. Of the remaining substitutions, 28 fell into one of the two pathogenic classes (IARC Class 4 or 5), 174 fell into one of the two nonpathogenic classes (IARC Class 1 or 2), and 15 remain in IARC Class 3, "Uncertain." The database is available at http://brca.iarc.fr/LOVD.
临床癌症易感性基因突变筛查中产生的未分类序列变异(UVs)给临床遗传学服务及其服务的患者带来了令人沮丧的问题。我们创建了一个开放获取的数据库,其中包含乳腺癌和卵巢癌易感基因 BRCA1 和 BRCA2 的错义替换。主要纳入标准是,每个变体都应该在使用贝叶斯综合评估未分类 BRCA 基因变体的已发表作品中进行了评估。从原始出版物向我们的数据库传输这些替换数据,为在单个模型下分析错义替换并消除在过去十年中综合评估演变过程中出现的不一致性提供了机会。这种分析还提供了根据最近发布的 IARC 5 级系统重新分类这些错义替换的机会。从最初的 248 个错义替换中,由于与剪接有不可忽略的概率干扰,有 31 个被搁置。在剩下的替换中,28 个属于两个致病性类别之一(IARC 类别 4 或 5),174 个属于两个非致病性类别之一(IARC 类别 1 或 2),15 个仍属于 IARC 类别 3,“不确定”。该数据库可在 http://brca.iarc.fr/LOVD 上获得。